<- Archives UCL - Programme d'études ->
Study programme 2012-2013
|
Version française
|
> Master in Management [120] - GEST2M - LLN
>
Programme
>
Admission
>
Contact
>
Teaching method
>
Mobility and/or Internationalisation outlook
Detailed Program
>
Core courses
>
Professional Focus [30.0]
>
Option courses and Exchanges
>
Elective courses semester 1
>
Options mobilité interuniversitaire - quadrimestre 1 (fr)
>
Elective courses semester 2
>
Corporate Finance (FIN3) LLN [15.0]
>
Bank Management (FIN4) LLN [15.0]
>
Finance 2 : Gestion de portefeuille et des risques (FIN2) - Mons [15.0]
>
Special Issues Marketing (SIMK) LLN [15.0]
>
Marketing 2 - MONS : Approches et méthodes avancées en marketing [15.0]
>
Management Research (MR) LLN [15.0]
>
Innovation in the Knowledge Economy (IN2) LLN [15.0]
>
Ressources humaines et organisations (RH2) LLN [15.0]
>
European Business II (EB2) LLN [15.0]
>
E-Business LLN [15.0]
>
Spécialisation en revisorat et expertise comptable 1 - MONS : Audit et Contrôle [15.0]
>
Managing Start-Ups (IN1) LLN [15.0]
>
Sourcing and Procurement - LLN - GSK Biologicals Partnership [15.0]
>
International Business - LLN [15.0]
>
Options mobilité interuniversitaire - quadrimestre 2 (fr)
>
EXCHANGE OR COURSES [0.0]
>
Entrepreneuriat - LLN - CPME [30.0]
>
Master in International Management (CEMS-MIM). [138.0]
Further Information
>
Faculty of the Louvain School of Management
Complete programme
>
Elective courses semester 2
Corporate Finance (FIN3) LLN [15.0]
Bank Management (FIN4) LLN [15.0]
Finance 2 : Gestion de portefeuille et des risques (FIN2) - Mons [15.0]
Special Issues Marketing (SIMK) LLN [15.0]
Marketing 2 - MONS : Approches et méthodes avancées en marketing [15.0]
Management Research (MR) LLN [15.0]
Innovation in the Knowledge Economy (IN2) LLN [15.0]
Ressources humaines et organisations (RH2) LLN [15.0]
European Business II (EB2) LLN [15.0]
E-Business LLN [15.0]
Spécialisation en revisorat et expertise comptable 1 - MONS : Audit et Contrôle [15.0]
Managing Start-Ups (IN1) LLN [15.0]
Sourcing and Procurement - LLN - GSK Biologicals Partnership [15.0]
International Business - LLN [15.0]
|
11/05/2011
|
